Search

Robert C Mucic

from La Crescenta, CA
Age ~51
Get Report
Also known as:
Robert Mucic, Robert Dr Mucic, Robert Christopher Mucic, Robert Christopher Mucie, Bob Mucic, Rob Mucic, Robert Mucio
Phone and address:
3726 Cedarbend Dr, Glendale, CA 91214
(818) 957-1418
Related to:
David VowellEduardo Carrasquilla, 84Barbara Galt, 73Joselito D Laxa, 52Christian Carrasquilla, 28
Connected to:
Alejandro C Mucino, 50Amparo L Mucino, 69Ignacio R Mucino, 64Jessica Mucino, 30Nancy T Mucino, 38Gabriel S Mucio, 36Becky K Muck, 42Claudia R Muck, 79Diantha Muck, 53Harlen F Muck, 77

Robert Mucic Phones & Addresses

  • 3726 Cedarbend Dr, La Crescenta, CA 91214 (818) 957-1418
  • Cedarbend Dr, Glendale, CA 91201
  • 1043 Glenoaks Blvd, Glendale, CA 91202 (818) 547-2784
  • 652 Glenoaks Blvd, Glendale, CA 91202 (818) 265-1737
  • 1600 Bel Aire Dr, Glendale, CA 91201 (818) 500-0900
  • Los Angeles, CA
  • Evanston, IL
  • San Diego, CA

Work

Company: Medtronic Jul 2013 Position: Senior engineering mangager

Education

School / High School: Northwestern University Jan 1999 Specialities: Philosophy

Skills

Product Development • Medical Devices • R&D • Manufacturing • Materials Science • Design of Experiments • Cross Functional Team Leadership • Fda • Leadership • Design Control • Project Management • Validation • Business Development • Commercialization • Biotechnology • Lifesciences • Life Sciences • Process Engineering • Technology Transfer • Marketing • Characterization • Quality System • Iso 13485 • Engineering • Patents • Electrochemistry • Sensors • Product Launch • Gmp • Chemistry • Analysis • Start Ups • Engineering Management • Verification and Validation • Biomedical Engineering • Failure Analysis • Supply Chain Management • People Management • Standard Operating Procedure

Industries

Medical Devices

Resumes

Resumes

Robert Mucic Photo 1

Senior Engineering Mangager

View page
Location:
3726 Cedarbend Dr, La Crescenta, CA 91214
Industry:
Medical Devices
Work:
Medtronic
Senior Engineering Mangager
Medtronic Jan 2011 - Jun 2013
Process Engineering Manager - Sensor Research and Development
Rcm Consulting Chemistry and Medical Devices Oct 2007 - Dec 2010
Owner
Findlaw, Part of Thomson Reuters Nov 2007 - Sep 2009
Client Development Consultant
Osmetech Molecular Diagnostics Jul 2005 - Nov 2007
Principal Scientist, Development
Education:
Northwestern University Jan 1999
Northwestern University Dec 1995
Master of Science, Masters Uc San Diego Mar 1994
Bachelors, Bachelor of Science, Chemistry Northwestern University
Doctorates, Doctor of Philosophy, Chemistry
Skills:
Product Development
Medical Devices
R&D
Manufacturing
Materials Science
Design of Experiments
Cross Functional Team Leadership
Fda
Leadership
Design Control
Project Management
Validation
Business Development
Commercialization
Biotechnology
Lifesciences
Life Sciences
Process Engineering
Technology Transfer
Marketing
Characterization
Quality System
Iso 13485
Engineering
Patents
Electrochemistry
Sensors
Product Launch
Gmp
Chemistry
Analysis
Start Ups
Engineering Management
Verification and Validation
Biomedical Engineering
Failure Analysis
Supply Chain Management
People Management
Standard Operating Procedure

Business Records

Name / Title
Company / Classification
Phones & Addresses
Robert Mucic
Principal
Valley Lawyer Marketing
Legal Services Office · Legal Services, Nsk
3726 Cedarbend Dr, Glendale, CA 91214

Publications

Us Patents

Nanoparticles Having Oligonucleotides Attached Thereto And Uses Therefor

View page
US Patent:
6417340, Jul 9, 2002
Filed:
Oct 20, 2000
Appl. No.:
09/693352
Inventors:
Chad A. Mirkin - Wilmette IL
Robert L. Letsinger - Wilmette IL
Robert C. Mucic - Glendale CA
James J. Storhoff - Evanston IL
Robert Elghanian - Chicago IL
Assignee:
Nanosphere, Inc. - Northbrook IL
International Classification:
C07H 1900
US Classification:
536 231, 536 221, 536 243, 536 2433, 435 6, 435 71, 435 72
Abstract:
The invention provides methods of detecting a nucleic acid. The methods comprise contacting the nucleic acid with one or more types of particles having oligonucleotides attached thereto. In one embodiment of the method, the oligonucleotides are attached to nanoparticles and have sequences complementary to portions of the sequence of the nucleic acid. A detectable change (preferably a color change) is brought about as a result of the hybridization of the oligonucleotides on the nanoparticles to the nucleic acid. The invention also provides compositions and kits comprising particles. The invention further provides nanomaterials and nanostructures comprising nanoparticles and methods of nanofabrication utilizing the nanoparticles. Finally, the invention provides a method of separating a selected nucleic acid from other nucleic acids.

Nanoparticles Having Oligonucleotides Attached Thereto And Uses Therefor

View page
US Patent:
6495324, Dec 17, 2002
Filed:
Oct 20, 2000
Appl. No.:
09/693005
Inventors:
Chad A. Mirkin - Wilmette IL
Robert L. Letsinger - Wilmette IL
Robert C. Mucic - Glendale CA
James J. Storhoff - Evanston IL
Robert Elghanian - Chicago IL
Assignee:
Nanosphere, Inc. - Northbrook IL
International Classification:
C12Q 168
US Classification:
435 6, 536 221, 536 231, 536 243, 536 2433
Abstract:
The invention provides methods of detecting a nucleic acid. The methods comprise contacting the nucleic acid with one or more types of particles having oligonucleotides attached thereto. In one embodiment of the method, the oligonucleotides are attached to nanoparticles and have sequences complementary to portions of the sequence of the nucleic acid. A detectable change (preferably a color change) is brought about as a result of the hybridization of the oligonucleotides on the nanoparticles to the nucleic acid. The invention also provides compositions and kits comprising particles. The invention further provides nanomaterials and nanostructures comprising nanoparticles and methods of nanofabrication utilizing the nanoparticles. Finally, the invention provides a method of separating a selected nucleic acid from other nucleic acids.

Nanoparticles Having Oligonucleotides Attached Thereto And Uses Therefor

View page
US Patent:
6506564, Jan 14, 2003
Filed:
Jun 26, 2000
Appl. No.:
09/603830
Inventors:
Chad A. Mirkin - Wilmette IL
Robert L. Letsinger - Wilmette IL
Robert C. Mucic - Glendale CA
James J. Storhoff - Evanston IL
Robert Elghanian - Chicago IL
Thomas A. Taton - Chicago IL
Assignee:
Nanosphere, Inc. - Northbrook IL
International Classification:
C12Q 168
US Classification:
435 6, 536 221, 536 231, 536 243, 536 2433, 536 253
Abstract:
The invention provides methods of detecting a nucleic acid. The methods comprise contacting the nucleic acid with one or more types of particles having oligonucleotides attached thereto. In one embodiment of the method, the oligonucleotides are attached to nanoparticles and have sequences complementary to portions of the sequence of the nucleic acid. A detectable change (preferably a color change) is brought about as a result of the hybridization of the oligonucleotides on the nanoparticles to the nucleic acid. The invention also provides compositions and kits comprising particles. The invention further provides methods of synthesizing unique nanoparticle-oligonucleotide conjugates, the conjugates produced by the methods, and methods of using the conjugates. In addition, the invention provides nanomaterials and nanostructures comprising nanoparticles and methods of nanofabrication utilizing nanoparticles. Finally, the invention provides a method of separating a selected nucleic acid from other nucleic acids.

Detection Of Target Analytes Using Particles And Electrodes

View page
US Patent:
6541617, Apr 1, 2003
Filed:
Oct 27, 1999
Appl. No.:
09/428155
Inventors:
Cynthia C. Bamdad - Sharon MA
Robert C. Mucic - Glendale CA
Assignee:
Clinical Micro Sensors, Inc. - Pasadena CA
International Classification:
C07H 2102
US Classification:
536 231, 536243, 536253, 435 6, 436 94
Abstract:
The invention relates to the use of particles comprising binding ligands and electron transfer moieties (ETMs). Upon binding of a target analyte, a particle and a reporter composition are associated and transported to an electrode surface. The ETMs are then detected, allowing the presence or absence of the target analyte to be determined.

Nanoparticles Having Oligonucleotides Attached Thereto And Uses Thereof

View page
US Patent:
6582921, Jun 24, 2003
Filed:
Sep 20, 2001
Appl. No.:
09/961949
Inventors:
Chad A. Mirkin - Wilmette IL
Robert L. Letsinger - Wilmette IL
Robert C. Mucic - Glendale CA
James J. Storhoff - Evanston IL
Robert Elghanian - Chicago IL
Thomas A. Taton - Chicago IL
Assignee:
Nanosphere, Inc. - Northbrook IL
International Classification:
C12Q 168
US Classification:
435 6, 536 221, 536 231, 536 266
Abstract:
The invention provides methods of detecting a nucleic acid. The methods comprise contacting the nucleic acid with one or more types of particles having oligonucleotides attached thereto. In one embodiment of the method, the oligonucleotides are attached to nanoparticles and have sequences complementary to portions of the sequence of the nucleic acid. A detectable change (preferably a color change) is brought about as a result of the hybridization of the oligonucleotides on the nanoparticles to the nucleic acid. The invention also provides compositions and kits comprising particles. The invention further provides methods of synthesizing unique nanoparticle-oligonucleotide conjugates, the conjugates produced by the methods, and methods of using the conjugates. In addition, the invention provides nanomaterials and nanostructures comprising nanoparticles and methods of nanofabrication utilizing nanoparticles. Finally, the invention provides a method of separating a selected nucleic acid from other nucleic acids.

Nanoparticles Having Oligonucleotides Attached Thereto And Uses Therefor

View page
US Patent:
6610491, Aug 26, 2003
Filed:
Sep 28, 2001
Appl. No.:
09/966491
Inventors:
Chad A. Mirkin - Wilmette IL
Robert L. Letsinger - Wilmette IL
Robert C. Mucic - Glendale CA
James J. Storhoff - Evanston IL
Robert Elghanian - Chicago IL
Thomas A. Taton - Chicago IL
Assignee:
Nanosphere, Inc. - Northbrook IL
International Classification:
C12Q 166
US Classification:
435 6, 536 231, 536 253, 536 266
Abstract:
The invention provides methods of detecting a nucleic acid. The methods comprise contacting the nucleic acid with one or more types of particles having oligonucleotides attached thereto. In one embodiment of the method, the oligonucleotides are attached to nanoparticles and have sequences complementary to portions of the sequence of the nucleic acid. A detectable change (preferably a color change) is brought about as a result of the hybridization of the oligonucleotides on the nanoparticles to the nucleic acid. The invention also provides compositions and kits comprising particles. The invention further provides methods of synthesizing unique nanoparticle-oligonucleotide conjugates, the conjugates produced by the methods, and methods of using the conjugates. In addition, the invention provides nanomaterials and nanostructures comprising nanoparticles and methods of nanofabrication utilizing nanoparticles. Finally, the invention provides a method of separating a selected nucleic acid from other nucleic acids.

Nanoparticles Having Oligonucleotides Attached Thereto And Uses Therefor

View page
US Patent:
6645721, Nov 11, 2003
Filed:
Sep 20, 2001
Appl. No.:
09/957313
Inventors:
Chad A. Mirkin - Wilmette IL
Robert L. Letsinger - Wilmette IL
Robert C. Mucic - Glendale CA
James J. Storhoff - Evanston IL
Robert Elghanian - Skokie IL
Thomas A. Taton - Little Canada MN
Assignee:
Nanosphere, Inc. - Northbrook IL
International Classification:
C12Q 168
US Classification:
435 6, 536 221, 536 231, 536 243, 536 266
Abstract:
The invention provides methods of detecting a nucleic acid. The methods comprise contacting the nucleic acid with one or more types of particles having oligonucleotides attached thereto. In one embodiment of the method, the oligonucleotides are attached to nanoparticles and have sequences complementary to portions of the sequence of the nucleic acid. A detectable change (preferably a color change) is brought about as a result of the hybridization of the oligonucleotides on the nanoparticles to the nucleic acid. The invention also provides compositions and kits comprising particles. The invention further provides methods of synthesizing unique nanoparticle-oligonucleotide conjugates, the conjugates produced by the methods, and methods of using the conjugates. In addition, the invention provides nanomaterials and nanostructures comprising nanoparticles and methods of nanofabrication utilizing nanoparticles. Finally, the invention provides a method of separating a selected nucleic acid from other nucleic acids.

Nanoparticles Having Oligonucleotides Attached Thereto And Uses Therefor

View page
US Patent:
6673548, Jan 6, 2004
Filed:
Sep 28, 2001
Appl. No.:
09/966312
Inventors:
Chad A. Mirkin - Wilmette IL
Robert L. Letsinger - Wilmette IL
Robert C. Mucic - Glendale CA
James J. Storhoff - Evanston IL
Robert Elghanian - Chicago IL
Thomas A. Taton - Chicago IL
Assignee:
Nanosphere, Inc. - Northbrook IL
International Classification:
C12Q 168
US Classification:
435 6, 536 221, 536 231, 536 266
Abstract:
The invention provides methods of detecting a nucleic acid. The methods comprise contacting the nucleic acid with one or more types of particles having oligonucleotides attached thereto. In one embodiment of the method, the oligonucleotides are attached to nanoparticles and have sequences complementary to portions of the sequence of the nucleic acid. A detectable change (preferably a color change) is brought about as a result of the hybridization of the oligonucleotides on the nanoparticles to the nucleic acid. The invention also provides compositions and kits comprising particles. The invention further provides methods of synthesizing unique nanoparticle-oligonucleotide conjugates, the conjugates produced by the methods, and methods of using the conjugates. In addition, the invention provides nanomaterials and nanostructures comprising nanoparticles and methods of nanofabrication utilizing nanoparticles. Finally, the invention provides a method of separating a selected nucleic acid from other nucleic acids.
Control profile
Robert C Mucic from La Crescenta, CA, age ~51 Get Report